Clinical Trials Directory

Trials / Completed

CompletedNCT02628249

Rate-limiting Amino Acids in Endurance-trained Athlete

Application of Indicator Amino Acid Oxidation Method to Investigate the Rate-limiting Amino Acids in Endurance Trained Athlete

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
University of Toronto · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Protein requirements in individuals who participate in endurance-based exercise training have been suggested to be greater than the current recommended dietary allowance (RDA). The biological value of protein depends on the amino acid composition. As liebig's law of the minimum, the protein synthesis is limited due to the lack of single rate limiting amino acid. In this case, the first rate limiting amino acid determines protein intakes to maximize the protein synthesis. Adding a small amount of rate-limiting amino acid to the diet improves the biological value of its protein diet. The indicator amino acid oxidation (IAAO) method has clarified the individual amino acid requirement in children, normal healthy adult and clinical populations. however, the IAAO method has never been utilized for determining the first rate limiting amino acid. Therefore, the purpose of this study is to address of IAAO method to be applied for determining the rate-limiting amino acid in endurance athlete.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBase protein0.8 g/kg/d of protein provided as crystalline amino acid modeled after egg protein
DIETARY_SUPPLEMENTSufficient protein1.75 g/kg/d protein provided as crystalline amino acid modeled after egg protein.
DIETARY_SUPPLEMENTBranched chain amino acidsBranched chain amino acids modeled after egg protein.
DIETARY_SUPPLEMENTEssential amino acidsEssential amino acids modeled after egg protein.
DIETARY_SUPPLEMENTNon essential amino acidsNon essential amino acids modeled after egg protein.

Timeline

Start date
2015-09-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2015-12-11
Last updated
2019-04-01

Source: ClinicalTrials.gov record NCT02628249. Inclusion in this directory is not an endorsement.